The Trump administration’s latest step to tackle high drug prices has generated praise, criticism and a lot of questions from providers, payers and drugmakers. Modern Healthcare runs down five of the top questions.
Healthcare providers who care for refugees are faced with the financial strain of having fewer new patients as a result of the Trump administration’s limiting of the number of those admitted into the country under the program.
Cerner’s revenue was up 5% over the third quarter of 2017, hitting $1.34 billion. The EHR vendor continues to make progress on the $10 billion VA project.
The American Medical Association updated its mapping tool to better flag medically-underserved areas and the social determinants affecting patients’ health.
The majority of state Medicaid agencies are planning to issue raises next year for providers thanks to the stronger economy. States are also seeing the first drop in Medicaid enrollment in a decade.
The new CMS model is projected to save taxpayers and patients $17.2 billion over five years by shifting Medicare Part B drugs to price levels more closely aligned with what other countries pay.
Healthcare prices grew about 16% from 2012 to 2016, which was about three times the inflation rate, according to a new report from the Health Care Cost Institute.
About 20 months after its star-crossed plan to merge with Advocate crashed and burned, the health system in Chicago’s suburbs is betting big on specialization as well as outpatient care.
While the CMS approved North Carolina’s waiver to transition to managed care and offer federal funding to address social determinants of health, it rejected a proposal to use federal funds to pay doctors’ debt.